BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Leukocyte
,
Anticancer prodrugs
,
Doxorubicin
,
rs3825942
,
PBX1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IL13RA2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Aorta
Joint synovium
Testis seminiferous tubule
Pituitary gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Liver transplant disorder
Toxoplasmosis
Injury of integument
Bronchitis
Hypoxia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
TNF-Related Apoptosis-Inducing Ligand
Seminal Plasma Proteins
Thymidine
MIRN203 microRNA, human
S-Adenosylmethionine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
EMC10
PCK2
TRNL1
LCP2
KDM5A
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Silencing of IL13RA2 promotes partial epithelial-mesenchymal transition in hepatocellular carcinoma …
Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease.
Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in …
Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas.
Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applicatio…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of…
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ